Eric Adjei Boakye1,2, Kenton J Johnston1,2, Thiago A Moulin1, Paula M Buchanan1, Leslie Hinyard1, Betelihem B Tobo3, Sean T Massa4, Nosayaba Osazuwa-Peters3,4,5. 1. Saint Louis University Center for Health Outcomes Research (SLUCOR). 2. Department of Health Management and Policy. 3. Department of Epidemiology and Biostatistics, Saint Louis University College for Public Health and Social Justice. 4. Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine. 5. Saint Louis University Cancer Center, St. Louis, MO.
Abstract
OBJECTIVES: The aim of the study was to estimate hospitalization cost, and factors associated with hospitalization costs and length of stay (LOS) of patients treated for head and neck cancer in the United States. METHODS: Data on 71,440 weighted hospital admissions from the 2014 National Inpatient Sample with a diagnosis of head and neck cancer were examined. Multivariable linear regression models estimated factors associated with hospitalization costs, and negative binomial regression models were used to identify factors associated with hospital LOS. Factor variables included characteristics of the patient, clinical, and hospital characteristics. RESULTS: The average hospitalization cost was US $18,371 and the average LOS was 6.6 days. LOS was significantly associated with admissions involving bacterial infection, major operating procedures, chemo procedure, and radiation procedure as well as admissions at medium or small bed size hospitals, and rural hospitals. Admissions among black patients, elective admissions, admissions involving bacterial infection, major operating procedures, chemo procedure, radiation procedure, and advance comorbidities were associated with increased hospitalization costs. In contrast, admissions at urban nonteaching or rural had increased hospitalization costs. CONCLUSIONS: Admissions that involve higher number of comorbidities, metastasis, bacterial infection, radiation, and chemo procedures had longer hospital stay and higher cost whereas admissions are rural hospitals had shorter hospital stay and lower cost. Understanding these factors associated with increased LOS and hospitalization cost will help efforts to decrease health care cost and improve quality of care.
OBJECTIVES: The aim of the study was to estimate hospitalization cost, and factors associated with hospitalization costs and length of stay (LOS) of patients treated for head and neck cancer in the United States. METHODS: Data on 71,440 weighted hospital admissions from the 2014 National Inpatient Sample with a diagnosis of head and neck cancer were examined. Multivariable linear regression models estimated factors associated with hospitalization costs, and negative binomial regression models were used to identify factors associated with hospital LOS. Factor variables included characteristics of the patient, clinical, and hospital characteristics. RESULTS: The average hospitalization cost was US $18,371 and the average LOS was 6.6 days. LOS was significantly associated with admissions involving bacterial infection, major operating procedures, chemo procedure, and radiation procedure as well as admissions at medium or small bed size hospitals, and rural hospitals. Admissions among black patients, elective admissions, admissions involving bacterial infection, major operating procedures, chemo procedure, radiation procedure, and advance comorbidities were associated with increased hospitalization costs. In contrast, admissions at urban nonteaching or rural had increased hospitalization costs. CONCLUSIONS: Admissions that involve higher number of comorbidities, metastasis, bacterial infection, radiation, and chemo procedures had longer hospital stay and higher cost whereas admissions are rural hospitals had shorter hospital stay and lower cost. Understanding these factors associated with increased LOS and hospitalization cost will help efforts to decrease health care cost and improve quality of care.
Authors: Gabriel Raab; Daniel Restifo; Sean M McBride; Richard J Wong; Nancy Y Lee; Armin Shahrokni; Kaveh Zakeri Journal: J Geriatr Oncol Date: 2021-10-28 Impact factor: 3.599
Authors: Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Betty Chen; Miao Cai; Betelihem B Tobo; Sai D Challapalli; Paula Buchanan; Jay F Piccirillo Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-05-01 Impact factor: 6.223
Authors: Riccardo Lemini; Iktej S Jabbal; Krystof Stanek; Shalmali R Borkar; Aaron C Spaulding; Scott R Kelley; Dorin T Colibaseanu Journal: BMC Surg Date: 2021-03-25 Impact factor: 2.102
Authors: Patrick Chaftari; Demis N Lipe; Monica K Wattana; Aiham Qdaisat; Pavitra P Krishnamani; Jomol Thomas; Ahmed F Elsayem; Marcelo Sandoval Journal: JCO Oncol Pract Date: 2021-12-14
Authors: Rita De Berardinis; Paolo Guiddi; Sara Ugolini; Francesco Chu; Giacomo Pietrobon; Gabriella Pravettoni; Fabrizio Mastrilli; Susanna Chiocca; Mohssen Ansarin; Marta Tagliabue Journal: Front Psychiatry Date: 2021-06-16 Impact factor: 4.157